ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Genmab A/S 

Toldbodgade 33

Copenhagen    K-1253  Denmark
Phone: 45-7020-2728 Fax: 45-7020-2729


SEARCH JOBS


 Key Statistics


Email:
Ownership: Public

Web Site: Genmab A/S
Employees:
Symbol: GEN.CO
 



Industry
Biotechnology


Collaborations

Bionomics Limited  Anti-angiogenesis therapeutic antibody development





 Company News
Genmab A/S (GEN.CO) Announces Phase 2 Study Of Daratumumab In Non-Hodgkin's Lymphomas 12/4/2014 10:28:38 AM
Genmab A/S (GEN.CO) Announces Additional Data From Phase 3 Study Of Ofatumumab As Maintenance Therapy For Relapsed CLL 11/6/2014 7:18:31 AM
Genmab A/S (GEN.CO) Moves Cancer Drug Pact To Novartis AG (NVS) From GlaxoSmithKline (GSK) 11/3/2014 6:24:32 AM
Genmab A/S (GEN.CO) Banks $10 Million Milestone Payment From Janssen Biotech Inc. (JNJ) 10/24/2014 7:26:33 AM
Seattle Genetics, Inc. (SGEN), Genmab A/S (GEN.CO) Partner In $211 Million Antibody-Drug Pact 9/10/2014 6:39:01 AM
Genmab A/S (GEN.CO) Release: Major Shareholder Announcement 8/25/2014 10:23:44 AM
Genmab A/S (GEN.CO) Announces New Phase 3 Study Of Daratumumab In Front Line Multiple Myeloma 8/11/2014 7:34:33 AM
Genmab A/S (GEN.CO), GlaxoSmithKline (GSK)'s Ofatumumab Meets Primary Endpoint In Late-Stage Study 8/1/2014 6:24:10 AM
Genmab A/S (GEN.CO) Announces Phase 3 Study Of Daratumumab In Front Line Multiple Myeloma 7/18/2014 7:43:42 AM
Genmab A/S (GEN.CO) To Receive Milestone Payment In Duobody Platform Collaboration With Janssen Biotech Inc. (JNJ) 7/14/2014 9:04:36 AM
12345678910...